alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000814576
<NAME>                        PAINEWEBBER R&D PARTNERS II, L.P.

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         6,998
<SECURITIES>                                   10,002,649
<RECEIVABLES>                                  1,550,000
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               11,559,647
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 11,559,647
<CURRENT-LIABILITIES>                          156,515
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     11,403,132
<TOTAL-LIABILITY-AND-EQUITY>                   11,559,647
<SALES>                                        0
<TOTAL-REVENUES>                               10,500,047
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               290,934
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                10,209,113
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   10,209,113
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0


</TABLE>
# C_2015381EN.01003501.xml

| 16.11.2015 | EN | Official Journal of the European Union | C 381/35 |
| --- | --- | --- | --- |

16.11.2015

EN

Official Journal of the European Union

C 381/35

---

Order of the General Court of 3 September 2015 — Spain v Commission

(Case T-676/14) (1)

1

((Action for annulment - Article 8(3) of Regulation (EU) No 1173/2011 - Effective enforcement of budgetary surveillance in the euro area - Manipulation of statistics - Commission decision to initiate an investigation - Act not amenable to review - Preparatory act - Inadmissibility))

(2015/C 381/40)

Language of the case: Spanish

Parties

Parties

Applicant: Kingdom of Spain (represented by: A. Rubio González, Abogado del Estado)

Applicant:

Defendant: European Commission (represented by: J.-P. Keppenne, J. Baquero Cruz and M. Clausen, acting as Agents)

Defendant:

Re:

Re:

Action for annulment of Commission Decision C(2014) 4856 final of 11 July 2014 on launching of an investigation related to the manipulation of statistics in Spain as referred to in Regulation (EU) No 1173/2011 of the European Parliament and of the Council on the effective enforcement of budgetary surveillance in the euro area.

Operative part of the order

Operative part of the order

| 1. | The action is dismissed as inadmissible. |
| --- | --- |

1.

The action is dismissed as inadmissible.

| 2. | The Kingdom of Spain shall pay the costs. |
| --- | --- |

2.

The Kingdom of Spain shall pay the costs.

---

(1)  OJ C 388, 3.11.2014.

1

---
EXHIBIT 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In connection  with the  quarterly  report of Avitar,  Inc.  (the  "Company") on
Form10-QSB for the period ending March 31, 2004 as filed with the Securities and
Exchange  Commission on the date hereof (the  "Report"),  I, Peter P.  Phildius,
Chief Executive  Officer of the Company certify,  pursuant to 18 U.S.C.  Section
1350, as adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, to
my knowledge, that:

     (1) The Report  fully  complies  with the  requirements  of  Section  13(a)
or15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Date: May 17, 2004

                                                 /s/ Peter P. Phildius
                                                 ---------------------
                                                 Peter P. Phildius Chief
                                                 Executive Officer
**Exhibit 23**

**Consent of Independent Registered Public Accounting Firm**

The Board of Directors 

ViroPharma Incorporated: 

We consent to the incorporation by reference in theregistration statements on Form S-8 (No. 333-136447, No. 333-34129, No. 333-38248, No. 333-60951, No. 333-38256, No. 333-109600 and No. 333-127188) and registration statements on Form S-3 (No. 333-37960,No. 333-64482, No. 333-99533, No. 333-122315, No. 333-123994, and No. 333-141411) of ViroPharma Incorporated of our reports dated February 28, 2008, with respect to the consolidated balance sheets of ViroPharmaIncorporated as of December 31, 2007 and 2006, and the related consolidated statements of operations, comprehensive income, stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2007 andthe effectiveness of internal control over financial reporting as of December 31, 2007, which reports appear in the December 31, 2007 Annual Report on Form 10-K of ViroPharma Incorporated. Our report on the consolidated financialstatements refers to the Company’s adoptions of the provisions of Financial Accounting Standards Board Interpretation No. 48, “Accounting for Uncertainty in Income Taxes” effective January 1, 2007 and Statement of FinancialAccounting Standards No. 123R, “Share-Based Payment,” effective January 1, 2006.
EX-32

          SECTION 1350 CERTIFICATION OF EDWARD H. WEBB

                   SECTION 1350 CERTIFICATION

In connection with the quarterly report of W-J International,
Ltd. ("Company") on Form 10-QSB for the quarter ended June 30, 2004 as
filed with the Securities and Exchange Commission ("Report"), the
undersigned, in the capacity and on the date indicated below, hereby
certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(18 U.S.C. Section 1350) that to his knowledge:

1.  The Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

2.  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations
of the Company.


Dated: August 12, 2004                 By: /s/  Edward H. Webb
                                       Edward H. Webb, President
# C_2014303EN.01002802.xml

| 8.9.2014 | EN | Official Journal of the European Union | C 303/28 |
| --- | --- | --- | --- |

8.9.2014

EN

Official Journal of the European Union

C 303/28

---

Action brought on 2 July 2014 — European Commission v Kingdom of Belgium

(Case C-317/14)

2014/C 303/36

Language of the case: French

Parties

Parties

Applicant: European Commission (represented by: J. Enegren and D. Martin, acting as Agents)

Applicant:

Defendant: Kingdom of Belgium

Defendant:

Form of order sought

Form of order sought

The Commission claims that the Court should:

| — | find that, in requiring persons applying for positions with local services established in French-speaking or German-speaking regions who do not have diplomas or certificates to show that they have completed their studies in the language concerned to obtain the certificate issued by SELOR (having taken the exam organised by that body), and in making that certificate the only way in which those persons can prove that they have the language skills needed for such positions, the Kingdom of Belgium has failed to fulfil its obligations under Article 45 TFEU and Regulation (EU) No 492/2011 of the European Parliament and of the Council of 5 April 2011 on freedom of movement for workers within the Union; (1) |
| --- | --- |

—

find that, in requiring persons applying for positions with local services established in French-speaking or German-speaking regions who do not have diplomas or certificates to show that they have completed their studies in the language concerned to obtain the certificate issued by SELOR (having taken the exam organised by that body), and in making that certificate the only way in which those persons can prove that they have the language skills needed for such positions, the Kingdom of Belgium has failed to fulfil its obligations under Article 45 TFEU and Regulation (EU) No 492/2011 of the European Parliament and of the Council of 5 April 2011 on freedom of movement for workers within the Union; (1)

1

| — | order the Kingdom of Belgium to pay the costs. |
| --- | --- |

—

order the Kingdom of Belgium to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

The condition, set out in Belgian legislation, under which persons applying for vacant positions with local public services in French-speaking or German-speaking regions who do not have diplomas to show that they have completed their studies in the language concerned are required to prove their language skills before they can fill such positions and are given only one way in which they can do so constitutes discrimination prohibited by Article 45 TFEU and Regulation (EU) No 492/2011.

---

(1)  OJ 2011 L 141, p. 1.

1

---
EXHIBIT 32



<PAGE>



      In connection with the Annual Report of Royce Biomedical, Inc. (the
"Company") on Form 10-KSB for the period ending June 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), Kathy
Jiang, the Chief Executive Officer and Chief Financial Officer of the Company,
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that to the best of her knowledge:

(1)  The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects the financial condition and results of the Company.


                                  By: /s/ Kathy Jiang
                                      ----------------------------------
                                      Kathy Jiang, Chief Executive and
                                      Principal Financial Officer
September 26, 2003
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-2000
<CASH>                                             883
<SECURITIES>                                     2,929
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 3,812
<PP&E>                                          43,408
<DEPRECIATION>                                  25,126
<TOTAL-ASSETS>                                  29,194
<CURRENT-LIABILITIES>                          598,170
<BONDS>                                              0
<PREFERRED-MANDATORY>                          739,696
<PREFERRED>                                     28,923
<COMMON>                                    21,297,570
<OTHER-SE>                                   (568,976)
<TOTAL-LIABILITY-AND-EQUITY>                    29,194
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                    5,131
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-BASIC>                                          0
<EPS-DILUTED>                                   (0.01)


</TABLE>
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1705 Triglyceride test system. ( a ) *Identification.* A triglyceride test system is a device intended to measure triglyceride (neutral fat) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism, or various endocrine disorders.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2308, Jan. 14, 2000]
§ 74.3054 D&C Black No. 4. ( a ) *Identity.* The color additive D&C Black No. 4 is a high-purity carbon black prepared by the oil furnace process. It is manufactured by the combustion of aromatic petroleum oil feedstock and consists essentially of pure carbon, formed as aggregated fine particles with a surface area range of 50 to 260 meters (m)2/gram.
( b ) *Specifications.* D&C Black No. 4 must conform to the following specifications and must be free from impurities other than those named to the extent that such other impurities may be avoided by good manufacturing practice: ( 1 ) Surface area by nitrogen BET (Brunauer, Emmett, Teller) method, 50 to 260 m2/gram.
( 2 ) Weight loss on heating at 950 °C for 7 minutes (predried for 1 hour at 125 °C), not more than 2 percent.
( 3 ) Ash content, not more than 0.15 percent.
( 4 ) Arsenic (total), not more than 3 milligrams per kilogram (mg/kg) (3 parts per million).
( 5 ) Lead (total), not more than 10 mg/kg (10 parts per million).
( 6 ) Mercury (total), not more than 1 mg/kg (1 part per million).
( 7 ) Total sulfur, not more than 0.65 percent.
( 8 ) Total polycyclic aromatic hydrocarbons (PAHs), not more than 0.5 mg/kg (500 parts per billion).
( 9 ) Benzo[*a*]pyrene, not more than 0.005 mg/kg (5 parts per billion).
( 10 ) Dibenz[*a,h*]anthracene, not more than 0.005 mg/kg (5 parts per billion).
( 11 ) Total color (as carbon), not less than 95 percent.
( c ) *Uses and restrictions.* ( 1 ) D&C Black No. 4 may be safely used at a level not to exceed 1.0 percent by weight of the suture material for coloring ultra-high molecular weight polyethylene non-absorbable sutures for general surgical use.
( 2 ) Authorization and compliance with this use must not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act with respect to the ultra-high molecular weight polyethylene surgical sutures in which D&C Black No. 4 is used.
( d ) *Labeling.* The label of the color additive must conform to the requirements of § 70.25 of this chapter.
( e ) *Certification.* All batches of D&C Black No. 4 must be certified in accordance with regulations in part 80 of this chapter.
[83 FR 26359, June 7, 2018]
#### § 1230.10 Placement.

The label or sticker shall be so firmly attached to the container that it will remain thereon while the container is being used, and be so placed as readily to attract attention.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 07-6144

WILLIAM ANDREW ESTES,

Petitioner - Appellant,

versus

JAMES HARDY, Administrator,

Respondent - Appellee.

Appeal from the United States District Court for the Western

District of North Carolina, at Bryson City. Lacy H. Thornburg,

District Judge. (2:06-cv-00019)

Submitted: May 10, 2007 Decided: May 15, 2007

Before MOTZ and DUNCAN, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

William Andrew Estes, Appellant Pro Se. Clarence Joe DelForge, III,

NORTH CAROLINA DEPARTMENT OF JUSTICE, Raleigh, North Carolina, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.
- 2 -

PER CURIAM:

William Andrew Estes seeks to appeal the district court’s

order dismissing as untimely his 28 U.S.C. § 2254 (2000) petition.

The order is not appealable unless a circuit justice or judge

issues a certificate of appealability. 28 U.S.C. § 2253(c)(1)

(2000). A certificate of appealability will not issue absent “a

substantial showing of the denial of a constitutional right.” 28

U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this standard by

demonstrating that reasonable jurists would find that any

assessment of the constitutional claims by the district court is

debatable or wrong and that any dispositive procedural ruling by

the district court is likewise debatable. Miller-El v. Cockrell,

537 U.S. 322, 336-38 (2003); Slack v. McDaniel, 529 U.S. 473, 484

(2000); Rose v. Lee, 252 F.3d 676, 683-84 (4th Cir. 2001). We have

independently reviewed the record and conclude that Estes has not

made the requisite showing. Accordingly, we deny Estes’ motion for

a certificate of appealability and dismiss the appeal. We dispense

with oral argument because the facts and legal contentions are

adequately presented in the materials before the court and argument

would not aid the decisional process. 

DISMISSED
Exhibit 32

# CERTIFICATION

The undersigned certify pursuant to
18 U.S.C. § 1350, that:

(1)
          The accompanying Quarterly Report on Form 10-Q for the period ended June 30,
          2005, fully complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and

(2)
          The information contained in the accompanying Report fairly presents, in all
          material respects, the financial condition and results of operations of the
          Company.

Date: August 5, 2005

| | /s/  Marti Morfitt                                
| | --------------------------------------------------
| | Marti Morfitt, President & Chief Executive Officer

Date: August 5, 2005

| | /s/  Samuel E. Reinkensmeyer                                                            
| | ----------------------------------------------------------------------------------------
| | Samuel E. Reinkensmeyer
Vice President of Finance, Chief
Financial Officer and Treasurer
I 

118TH CONGRESS 

1ST SESSION H. R. 780 

To prohibit the receipt of Federal financial assistance by sanctuary cities, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2023 

Mr. DUNCAN (for himself, Mr. BIGGS, Mrs. HARSHBARGER, Mr. NORMAN, 

Mrs. MILLER of Illinois, Mr. GOSAR, Mr. PERRY, Mr. MOONEY, Mr. 

MOORE of Alabama, Mr. JACKSON of Texas, Mr. POSEY, Mr. ZINKE, and 

Mr. CARTER of Georgia) introduced the following bill; which was referred 

to the Committee on the Judiciary, and in addition to the Committee on 

Oversight and Accountability, for a period to be subsequently determined 

by the Speaker, in each case for consideration of such provisions as fall 

within the jurisdiction of the committee concerned 

A BILL 

To prohibit the receipt of Federal financial assistance by 

sanctuary cities, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Mobilizing Against 

5 Sanctuary Cities Act’’. 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 780 IH

1 SEC. 2. SANCTUARY CITIES INELIGIBLE FOR FEDERAL FI2 NANCIAL ASSISTANCE. 

3 Any State or local government that violates section 

4 642 of the Illegal Immigration Reform and Immigrant Re5 sponsibility Act of 1996 (8 U.S.C. 1373) may not receive 

6 any Federal financial assistance (as such term is defined 

7 in section 7501(a)(5) of title 31, United States Code). The 

8 Attorney General shall determine annually which State or 

9 local jurisdictions are not in compliance with section 642 

10 of the Illegal Immigration Reform and Immigrant Respon11 sibility Act and shall report such determinations to Con12 gress on March 1 of each year. The Attorney General shall 

13 also issue a report concerning the compliance of any par14 ticular State or local jurisdiction at the request of any 

15 Member of Congress. Any jurisdiction that is found to be 

16 out of compliance shall be ineligible to receive Federal fi17 nancial assistance for a minimum period of one year, and 

18 shall only become eligible again after the Attorney General 

19 certifies that the jurisdiction is in compliance. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from form 10-Q
and is qualified in its entirety by reference to such financial statements
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                          14,847
<SECURITIES>                                         0
<RECEIVABLES>                                1,411,610
<ALLOWANCES>                                         0
<INVENTORY>                                  1,053,253
<CURRENT-ASSETS>                             2,694,068
<PP&E>                                         892,022
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               3,679,951
<CURRENT-LIABILITIES>                        1,454,388
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         6,475
<OTHER-SE>                                  10,368,686
<TOTAL-LIABILITY-AND-EQUITY>                 3,679,951
<SALES>                                      2,795,623
<TOTAL-REVENUES>                             2,795,623
<CGS>                                        1,922,453
<TOTAL-COSTS>                                  671,049
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              61,450
<INCOME-PRETAX>                                140,671
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            140,671
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   140,671
<EPS-BASIC>                                        .02
<EPS-DILUTED>                                      .02


</TABLE>